|
시장보고서
상품코드
2141577
의료기기용 열가소성 엘라스토머 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Thermoplastic Elastomers in Medical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 의료기기용 열가소성 엘라스토머 시장 규모는 2025년에 33억 달러로 평가되며, CAGR 4.7%로 확대되어 2035년까지 53억 달러에 달할 것으로 추정됩니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 시작 시점 시장 규모 | 33억 달러 |
| 예측액 | 53억 달러 |
| CAGR | 4.7% |
열가소성 엘라스토머(TPE)는 틈새 소재에서 현대 의료기기 제조에 없어서는 안 될 핵심 구성요소로 꾸준히 진화해 왔습니다. 탄력성, 생체적합성, 효율적인 가공성을 겸비한 이 소재의 특성은 내구성이 뛰어나고 환자 친화적인 의료 기술에 대한 수요 증가를 뒷받침하고 있습니다. 의료 종사자들은 일관된 성능을 발휘하면서도 환자의 편의성을 향상시키는 솔루션을 점점 더 중요하게 여기게 되면서, TPE는 차세대 의료기기 개발에서 선호되는 소재군으로서의 입지를 확고히 하고 있습니다. 엄격한 안전 기준과 환경 규제를 배경으로, 지속가능성과 책임 있는 소재 관리는 의료용 TPE 분야에서 핵심 과제가 되고 있습니다. 환경 부하가 낮고 높은 멸균 내성을 갖춘 재활용 가능한 소재로의 전환이 그 채택을 지속적으로 가속화하고 있습니다. 지속적인 혁신을 통해 배합의 안전성, 기계적 안정성, 내화학성 및 전반적인 수명이 향상되면서, 기존 엘라스토머와 관련된 오랜 우려 사항들이 해소되고 있습니다. 지속적인 임상시험 및 환경 시험은 보다 안전한 의료 결과를 뒷받침하는 동시에, 재료 과학의 발전을 위해 노력하는 업계의 자세를 반영하고 있습니다.
열가소성 폴리우레탄(TPU)은 2025년에 52.4%의 시장 점유율을 차지했으며, 2035년까지 연평균 성장률(CAGR) 5%로 성장할 것으로 전망됩니다. TPU는 유연성과 강도의 균형이 뛰어나며, 구조적 신뢰성을 저해하지 않으면서도 부드러움을 정밀하게 제어할 수 있기 때문에 여전히 가장 널리 채택되고 있는 의료용 TPE입니다. 이러한 특성들은 복잡한 의료 공학적 요구 사항을 충족하고, 광범위한 의료 용도에서 일관된 성능을 발휘하는 데 기여하고 있습니다.
카테터·튜브 분야는 2025년에 28.7%의 점유율을 차지했으며, 2026년부터 2035년까지 연평균 성장률(CAGR) 5.5%로 성장할 것으로 전망됩니다. 이러한 우위는 장기간의 사용 주기 동안 생체적합성, 유연성 및 무균성을 유지할 수 있는 이 소재의 특성에 기인합니다. TPE는 일상적인 의료 시술부터 첨단 치료 시스템에 이르기까지 신뢰할 수 있는 성능을 보장함으로써 이 부문에서 그 중요성을 더욱 높이고 있습니다.
북미 의료기기용 열가소성 엘라스토머 시장은 2025년에 35%의 점유율을 차지했습니다. 이 지역은 성숙한 의료 인프라, 엄격한 규제 감독, 의료기기 제조업체의 집중이라는 강점을 가지고 있습니다. 폴리머 연구에 대한 지속적인 투자와 규정 준수를 중시하는 혁신을 통해 안전 기준, 기기의 기능성 및 환자 경험이 향상되어 이 지역의 리더십이 더욱 공고해지고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추정·예측 : TPE 화학 구조별, 2022-2035년
제6장 시장 추정·예측 : 용도별, 2022-2035년
제7장 시장 추정·예측 : 가공 방법별, 2022-2035년
제8장 시장 추정·예측 : 지역별, 2022-2035년
제9장 기업 개요
KSM 26.10.12The Global Thermoplastic Elastomers in Medical Devices Market was valued at USD 3.3 billion in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 5.3 billion by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $3.3 Billion |
| Forecast Value | $5.3 Billion |
| CAGR | 4.7% |
Thermoplastic elastomers have steadily evolved from niche materials into indispensable components within modern medical manufacturing. Their combination of elasticity, biocompatibility, and efficient processing supports the growing demand for durable, patient-friendly medical technologies. Healthcare providers increasingly prioritize solutions that deliver consistent performance while improving patient comfort, positioning TPEs as a preferred material class for next-generation device development. Sustainability and responsible material management have become central to the medical TPE landscape, driven by strict safety standards and environmental regulations. The shift toward recyclable materials with lower ecological impact and high sterilization resistance continues to accelerate adoption. Ongoing innovation addresses long-standing concerns related to conventional elastomers by improving formulation safety, mechanical stability, chemical resistance, and overall lifespan. Continuous clinical and environmental testing reflects the industry's commitment to advancing material science while supporting safer healthcare outcomes.
Thermoplastic Polyurethanes accounted for 52.4% share in 2025 and are forecast to grow at a CAGR of 5% through 2035. TPU remains the most widely adopted medical-grade TPE due to its balance of flexibility and strength, which allows precise control over softness without compromising structural reliability. These attributes support complex medical engineering requirements and contribute to consistent performance across a wide range of medical applications.
The catheters and tubing segment held a 28.7% share in 2025 and is anticipated to grow at a CAGR of 5.5% during 2026-2035. This dominance is supported by the material's ability to maintain biocompatibility, flexibility, and sterility throughout extended use cycles. TPEs ensure reliable performance across both routine medical procedures and advanced therapeutic systems, reinforcing their importance within this segment.
North America Thermoplastic Elastomers in Medical Devices Market held a 35% share in 2025. The region benefits from a mature healthcare infrastructure, rigorous regulatory oversight, and a strong concentration of medical device manufacturers. Continued investment in polymer research and compliance-focused innovation strengthens regional leadership by enhancing safety standards, device functionality, and patient experience.
Key companies operating in the Global Thermoplastic Elastomers in Medical Devices Market include Lubrizol Corporation, BASF SE, Covestro AG, Arkema, Dow Chemical, Kuraray, Kraiburg TPE, Teknor Apex, Hexpol/Elastron, RTP Company, Kraton, Evonik, Mitsubishi Chemical, Trinseo, and DSM Biomedical. Companies operating in the Thermoplastic Elastomers in Medical Devices Market focus on material innovation, regulatory alignment, and long-term partnerships to strengthen their competitive position. Manufacturers invest heavily in research to improve formulation safety, mechanical performance, and sterilization compatibility while meeting evolving compliance requirements. Strategic collaborations with medical device producers allow early integration of customized materials into product design cycles. Firms also prioritize sustainability initiatives by developing recyclable and low-impact elastomer solutions. Capacity expansion, geographic diversification, and portfolio optimization further support market penetration, while consistent quality assurance and clinical validation help build trust with healthcare providers and regulatory bodies.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional
- 2.2.2 TPE Chemistry
- 2.2.3 Application
- 2.2.4 Processing Method
- 2.3 TAM Analysis, 2026-2035
- 2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
- 2.5 Future Outlook and Strategic Recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Shift from PVC to phthalate-free alternatives
- 3.2.1.2 Growing demand for latex-free medical products
- 3.2.1.3 Aging population & chronic disease prevalence
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Higher material cost vs. Commodity PVC
- 3.2.2.2 Limited high-temperature resistance vs. Thermosets
- 3.2.3 Market opportunities
- 3.2.3.1 Sustainable & bio-based tpe formulations
- 3.2.3.2 Antimicrobial & infection-prevention materials
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- 3.7 Price trends
- 3.7.1 By region
- 3.7.2 By TPE Chemistry
- 3.8 Future market trends
- 3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
- 3.10 Patent Landscape
- 3.11 Trade statistics (HS code)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
- 3.13 Carbon footprint consideration
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New Product Launches
- 4.6.4 Expansion Plans
Chapter 5 Market Estimates and Forecast, By TPE Chemistry, 2022-2035 (USD Billion) (Kilo Tons)
- 5.1 Key trends
- 5.2 Thermoplastic Polyurethanes (TPU)
- 5.2.1 Polyether-Based TPU
- 5.2.2 Polyester-Based TPU
- 5.3 Styrenic Block Copolymers (TPE-S/SEBS)
- 5.3.1 SEBS (Hydrogenated Styrenic)
- 5.3.2 SBS & Other Styrenic Variants
- 5.4 Thermoplastic Vulcanizates (TPV)
- 5.4.1 PP/EPDM Dynamic Vulcanizates
- 5.5 Thermoplastic Copolyester Elastomers (COPE/TPC-ET)
- 5.5.1 Polyether Glycol/PBT Block Copolymers
- 5.6 Thermoplastic Polyamide Elastomers (PEBA/TPE-A)
- 5.7 Thermoplastic Olefin Elastomers (TPE-O/TPO)
Chapter 6 Market Estimates and Forecast, By Application, 2022-2035 (USD Billion) (Kilo Tons)
- 6.1 Key trends
- 6.2 Catheters & tubing
- 6.2.1 Intravenous (iv) catheters
- 6.2.2 Urological catheters
- 6.2.3 Cardiovascular catheters & balloon catheters
- 6.2.4 Single & multi-lumen medical tubing
- 6.2.5 Drug delivery & infusion tubing
- 6.3 Medical equipment & devices
- 6.3.1 Dental guards for bruxism disease
- 6.3.2 Peristaltic pump tubes
- 6.3.3 Urine catheter grips & components
- 6.3.4 Respiratory face masks & seals
- 6.4 Disposable medical goods
- 6.4.1 Throat swab brushes
- 6.4.2 Examination gloves (non-latex)
- 6.4.3 Disposable masks & garments
- 6.5 Medical films, bags & packaging
- 6.5.1 Iv & saline bags
- 6.5.2 Biopharmaceutical storage bags
- 6.5.3 Enteral & parenteral nutrition bags
- 6.5.4 Peritoneal & dialysis bags
- 6.6 Medical tips & gaskets
- 6.6.1 Infusion bottle caps & closures
- 6.6.2 Syringe gaskets & plunger tips
- 6.6.3 Vial stoppers & septa
- 6.7 Surgical & diagnostic instruments
- 6.7.1 Surgical instrument grips & handles
- 6.7.2 Diagnostic equipment housings
- 6.8 Medical footwear
- 6.9 Implantable devices & components
- 6.9.1 Surgical meshes (polymeric)
- 6.9.2 Polymeric prostheses components
- 6.9.3 Elastomeric implant blocks
Chapter 7 Market Estimates and Forecast, By Processing Method, 2022-2035 (USD Billion) (Kilo Tons)
- 7.1 Key trends
- 7.2 Injection Molding-Grade TPE
- 7.3 Extrusion-Grade TPE
- 7.4 Blow Molding-Grade TPE
- 7.5 Overmolding & Co-Injection Grade TPE
Chapter 8 Market Estimates and Forecast, By Region, 2022-2035 (USD Billion) (Kilo Tons)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 BASF SE
- 9.2 Lubrizol Corporation
- 9.3 Covestro AG
- 9.4 Dow Chemical
- 9.5 Arkema
- 9.6 Teknor Apex
- 9.7 Kraiburg TPE
- 9.8 Hexpol/Elastron
- 9.9 Kuraray
- 9.10 RTP Company
- 9.11 Evonik
- 9.12 Kraton
- 9.13 DSM Biomedical
- 9.14 Trinseo
- 9.15 Mitsubishi Chemical
